Lifco AB Series B
Lifco AB (publ) engages in the dental, demolition and tools, and systems solutions businesses in Sweden, Norway, Germany, rest of Europe, the United Kingdom, Asia, Australia, Italy, North America, and internationally. It is involved in the distribution of dental equipment, such as denture attachments, disinfectants, saliva ejectors, bite registration and dental impression materials, bonding agent… Read more
Lifco AB Series B (0R4P) - Total Liabilities
Latest total liabilities as of December 2021: Skr14.23 Billion SEK
Based on the latest financial reports, Lifco AB Series B (0R4P) has total liabilities worth Skr14.23 Billion SEK as of December 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Lifco AB Series B - Total Liabilities Trend (2021–2021)
This chart illustrates how Lifco AB Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Lifco AB Series B Competitors by Total Liabilities
The table below lists competitors of Lifco AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Orvana Minerals Corp
PINK:ORVMF
|
USA | $165.46 Million |
|
NSE SA
PA:ALNSE
|
France | €53.41 Million |
|
Athena Bitcoin Global
PINK:ABIT
|
USA | $23.59 Million |
|
Advance Synergy Bhd
KLSE:1481
|
Malaysia | RM154.43 Million |
|
Birla Cable Limited
NSE:BIRLACABLE
|
India | ₹1.62 Billion |
|
Bioceres Crop Solutions Corp
NASDAQ:BIOX
|
USA | $455.83 Million |
|
Jianpu Technology Inc
OTCQB:AIJTY
|
USA | $421.76 Million |
Liability Composition Analysis (2021–2021)
This chart breaks down Lifco AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.57 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lifco AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lifco AB Series B (2021–2021)
The table below shows the annual total liabilities of Lifco AB Series B from 2021 to 2021.
| Year | Total Liabilities | Change |
|---|---|---|
| 2021-12-31 | Skr14.23 Billion | -- |